RXO, Inc. (NYSE:RXO) Given Average Recommendation of “Hold” by Brokerages

Shares of RXO, Inc. (NYSE:RXOGet Free Report) have received an average rating of “Hold” from the fourteen brokerages that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $26.00.

Several analysts have commented on the company. Raymond James started coverage on RXO in a research note on Wednesday, May 15th. They set a “market perform” rating for the company. JPMorgan Chase & Co. lifted their price objective on shares of RXO from $25.00 to $26.00 and gave the company an “underweight” rating in a research report on Thursday, August 8th. Oppenheimer upped their price objective on shares of RXO from $22.00 to $31.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Jefferies Financial Group reduced their target price on shares of RXO from $33.00 to $31.00 and set a “buy” rating for the company in a research note on Tuesday, August 13th. Finally, UBS Group boosted their price target on shares of RXO from $22.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, August 8th.

View Our Latest Stock Report on RXO

RXO Stock Performance

Shares of RXO opened at $28.46 on Monday. The company’s 50 day simple moving average is $28.48 and its 200-day simple moving average is $23.37. The firm has a market cap of $3.35 billion, a PE ratio of -316.22, a price-to-earnings-growth ratio of 7.37 and a beta of 1.38. RXO has a 12-month low of $16.94 and a 12-month high of $32.82. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 EPS for the quarter, meeting analysts’ consensus estimates of $0.03. RXO had a negative net margin of 0.55% and a positive return on equity of 2.22%. The company had revenue of $930.00 million for the quarter, compared to analyst estimates of $934.14 million. During the same period in the previous year, the business posted $0.08 earnings per share. RXO’s quarterly revenue was down 3.4% on a year-over-year basis. As a group, equities analysts predict that RXO will post 0.14 EPS for the current year.

Institutional Investors Weigh In On RXO

Institutional investors and hedge funds have recently modified their holdings of the company. GAMMA Investing LLC purchased a new stake in RXO during the fourth quarter worth $27,000. Motco boosted its position in shares of RXO by 5,450.0% in the 1st quarter. Motco now owns 2,442 shares of the company’s stock worth $53,000 after buying an additional 2,398 shares in the last quarter. TFO Wealth Partners LLC boosted its position in shares of RXO by 106,833.3% in the 4th quarter. TFO Wealth Partners LLC now owns 3,208 shares of the company’s stock worth $70,000 after buying an additional 3,205 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in RXO by 2,235.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock valued at $80,000 after acquiring an additional 3,487 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in RXO during the 2nd quarter valued at about $112,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.